FindTrial
Sign In

Risk assessment algorithm for carotid plaque in patients with metabolic-associated fatty liver disease

Risk assessment algorithm for carotid plaque in patients with metabolic-associated fatty liver disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102929
Enrollment
Unknown
Registered
2025-05-21
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic-associated fatty liver disease

Interventions

MAFLD group:NA
non-MALFD group:NA

Sponsors

Beijing Ditan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Age of 18-45 years old, both sexes; 2. patients underwent carotid ultrasound examination; 3. patients underwent abdominal ultrasound examination.

Exclusion criteria

Exclusion criteria: 1. patients with other causes of liver disease; 2. patients with severe lung, kidney, blood and other important organ diseases with dysfunction; 3. patients with concurrent tumors; 4. The clinical data were incomplete.

Design outcomes

Primary

MeasureTime frame
carotid plaque;—

Secondary

MeasureTime frame
Carotid intima thickness;Coronary plaque;Coronary artery stenosis;—

Countries

China

Contacts

Public ContactHe Lingling

Beijing Ditan Hospital, Capital Medical University

lindahell@163.com+86 10 84322309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026